Advanced Cardiac Risk Markers

Following tests are a part of the Advanced cardiac risk markers package:

Apolipoprotein A-I (apo A-I) is a protein that plays an important role in the transportation and metabolism of lipids and is the main protein component in high-density lipoprotein. Apo A-I is ordered in someone who has a personal or family history of abnormal lipid levels and/or premature cardiovascular disease. It may be ordered when your doctor is trying to determine the cause of a person's high cholesterol.

The Homocysteine Test measures the levels of homocysteine in the blood. Homocysteine is an amino acid which at increased levels in the body can damage the inner lining of the blood vessels that increases the chances of blood clot formation. The Homocysteine Test measures the levels of homocysteine in the blood. The Homocysteine Test is performed to screen for heart attack and stroke, especially in people with no known risk factors but with a family history of cardiovascular diseases. This test also detects and diagnoses an inherited disease called homocystinuria in newborns and infants and even detects deficiency of Vitamin B6, B12, or Folic acid.

Apolipoprotein B/ A1 Ratio helps in evaluating your risk of developing cardiovascular disease (CVD); It is also used to monitor treatment for high cholesterol. This test is not widely used for a screening test but may be ordered if a person has a family history of heart disease and/or high cholesterol and triglycerides (hyperlipidemia).

High sensitive CRP: High sensitive C reactive protein is a test that measures the amount of C reactive protein in the blood. The level of this marker is elevated in cases of inflammation in the body. This test can evaluate your risk of heart diseases such as coronary artery disease.

Lipoprotein-A: This test measures the amount or activity of Lipoprotein in the blood. It helps in determining your risk of developing cardiovascular disease (CVD), including your risk of coronary heart disease (CHD) and ischemic stroke.

Apolipoprotein-B is ordered, when a healthcare practitioner is evaluating someone's risk of developing CVD and when a person has a personal or family history of heart disease and/or abnormal lipid levels, especially when the person has significantly elevated triglyceride levels.